eMedicine Specialties > Endocrinology > Adrenal Gland

Adrenal Hemorrhage: Differential Diagnoses & Workup

Author: Nicholas A Tritos, MD, DSc, MMSc, FACE, FACP, Assistant Professor of Medicine, Tufts University School of Medicine; Senior Staff Physician, Department of Endocrinology, Lahey Clinic Medical Center
Contributor Information and Disclosures

Updated: May 27, 2008

Differential Diagnoses

Adrenal Adenoma
Adrenal Carcinoma
Adrenal Crisis
Myocardial Infarction
Pheochromocytoma
Septic Shock

Other Problems to Be Considered

Acute (surgical) abdomen
Adrenal calcifications
Adrenal incidentaloma
Adrenal neuroblastoma
Granulomatous diseases

Workup

Laboratory Studies

  • Complete blood count (CBC) and differential generally are obtained to assist with therapeutic decisions, although these test results are nonspecific.
    • A significant decrease in hematocrit (at least 4%) or hemoglobin (at least 2 g/dL) occurs in approximately one half of patients with bilateral adrenal hemorrhage.
    • Leukocytosis frequently occurs in patients with adrenal hemorrhage, and it may be associated with the underlying cause of adrenal hemorrhage. Eosinophilia is present in only a small percentage of patients with adrenal hemorrhage.
  • Serum electrolytes, blood urea nitrogen (BUN), creatinine, and plasma glucose may be of limited diagnostic use, but they also should be obtained to assist with patient management.
    • Hyponatremia, hyperkalemia, and prerenal azotemia are present in approximately 50% of patients with extensive, bilateral adrenal hemorrhage. Mild hypercalcemia may rarely occur. Although the combination of low serum sodium and high serum potassium is suggestive of adrenal insufficiency in the appropriate clinical setting, their absence never should exclude this diagnosis.
    • Hypoglycemia may occur in patients with adrenal hemorrhage and adrenal insufficiency, but it rarely is severe.
  • Serum cortisol, plasma ACTH, serum aldosterone, and plasma renin activity (PRA) always should be obtained in suspected adrenal hemorrhage cases, because they provide important information on adrenal function.
    • In an acutely ill patient, the combination of increased plasma ACTH and low, or even low-normal (ie, <13 mcg/dL), serum cortisol is highly suggestive of glucocorticoid deficiency due to primary adrenal insufficiency. Conversely, a serum cortisol of over 25 mcg/dL in an acutely ill patient excludes glucocorticoid deficiency. The combination of low serum aldosterone and increased PRA suggests mineralocorticoid deficiency.
    • In order to provide useful diagnostic information, blood samples for these tests should be obtained before glucocorticoid administration, because several exogenous glucocorticoids (hydrocortisone and prednisone, but not dexamethasone) cross-react with endogenous cortisol in radioimmunoassay.
    • Because results are not available immediately, these tests are not helpful in the acute setting, but they provide retrospective diagnostic information.
  • The short Cortrosyn stimulation test confirms the diagnosis of adrenal insufficiency.
    • This test involves the bolus intravenous or intramuscular administration of the ACTH analog cosyntropin (Cortrosyn, 250 mcg) and serum collection 1 hour after cosyntropin administration for cortisol assay. A peak serum cortisol of over 20 mcg/dL (1 h after cosyntropin administration) indicates normal adrenal response in a nonstressed individual.
    • Although the normal adrenal response to cosyntropin has not been defined precisely in acutely ill patients, individuals with bilateral adrenal hemorrhage and clinical evidence of adrenal insufficiency have a markedly blunted adrenal response, according to the above criteria, in this test.
    • Measurement of the aldosterone response to Cortrosyn administration has been advocated in order to assess mineralocorticoid reserve. Serum samples are obtained immediately before and 30 minutes after the administration, as above, of intravenous cosyntropin. Either a peak serum aldosterone of over 16 ng/dL or a rise in serum aldosterone of at least 4 ng/dL indicates a normal adrenal response.
    • Although the short Cortrosyn stimulation test is the criterion standard for the diagnosis of adrenal insufficiency, its performance may not be practical in the acute setting, particularly in a hypotensive or otherwise unstable patient. In these cases, only basal cortisol and ACTH levels need to be obtained before urgent glucocorticoid administration, and the more definitive Cortrosyn stimulation test can be performed after the patient has been stabilized. Alternatively, because the presence of dexamethasone does not interfere with cortisol immunoassays, this medication can be administered to stabilize the condition of a patient with suspected adrenal insufficiency, before the short Cortrosyn stimulation test is performed.
    • Because the results of the short Cortrosyn stimulation test are not available immediately, this test is not helpful in the acute setting to guide management decisions, but it provides retrospective confirmation of adrenal insufficiency.

Imaging Studies

  • Computed tomography (CT) scanning of the adrenals (thin slice) is the study of choice for demonstrating adrenal hemorrhage in the acute setting.10
    • CT scanning is practical only in hemodynamically stable patients.
    • CT scanning of patients with adrenal hemorrhage shows adrenal enlargement that may be asymmetric in cases of bilateral adrenal hemorrhage. The glands become rounded or oval shaped and have high attenuation (50-90 Hounsfield units) without contrast enhancement in the acute setting.
    • In cases of unilateral, traumatic adrenal hemorrhage, a streaky appearance of the perirenal fat frequently is observed posterior to the gland.11 This finding is not specific to traumatic adrenal hemorrhage, because it also has been observed in patients with adrenal hemorrhage and metastatic tumors to the adrenals. Extension of the hemorrhage into the perirenal space, with perinephric hematoma formation, has been observed in patients with metastatic disease.
    • Associated findings may include a mixed-density, inhomogeneous mass in patients with primary or metastatic cancer. Significant contrast enhancement further suggests the presence of an associated lesion (such as pheochromocytoma or metastatic tumor).
    • Several weeks after the acute adrenal hemorrhage, CT scanning shows a gradual decrease in adrenal size and attenuation. In addition, the adrenals may have a cystic appearance.
    • Several months after the acute event, CT scanning of the adrenals shows progressive atrophy, with the variable appearance of calcifications. The presence of adrenal calcifications does not invariably indicate a previous episode of adrenal hemorrhage, because this finding also is associated with adrenal cysts, adrenocortical adenomas and carcinomas, pheochromocytomas, neuroblastomas (only in children), metastatic tumors, and granulomatous diseases, including tuberculosis and histoplasmosis.
  • Magnetic resonance imaging (MRI) may be used to help exclude the presence of malignant tumors or pheochromocytomas, and it may provide an estimate of the age of the hematoma.12,13
    • Less experience with the use of MRI in adrenal hemorrhage exists in comparison with CT scanning.
    • Acutely (ie, 24-72 h after onset), the adrenals are enlarged. Adrenal hemorrhage appears isointense with normal liver and muscle on T1-weighted images and appears hyperintense to the liver on T2-weighted images. Stranding of the perirenal and even subcutaneous fat has been observed in T2-weighted images in traumatic adrenal hemorrhage cases.
    • Subacutely (ie, approximately 3-7 d after onset), adrenal hemorrhage shows intermediate intensity on T1- and T2-weighted images. This appearance has been associated with the presence of deoxyhemoglobin in the adrenal hemorrhagic area. In addition, a hyperintense ring frequently is observed outlining the adrenals (on T1- and T2-weighted images). This hyperintense ring gradually may fill in centrally, and it appears to be secondary to the presence of free methemoglobin.
    • At a more chronic stage (ie, several wk after onset), MRI shows a decrease in adrenal size. In addition, adrenal hemorrhagic areas become hyperintense with a hypointense rim on T1- and T2-weighted images. The centrally located, high signal intensity may be secondary to the presence of free methemoglobin, and the hypointense rim has been associated with the presence of hemosiderin-laden macrophages in the fibrous capsule. Furthermore, necrotic areas in the adrenal hemorrhagic area may create a more heterogeneous appearance, with areas of low signal intensity on T1-weighted images.
    • In a suspected adrenal hemorrhage case, the lack of enhancement after gadolinium–diethylenetriamine penta-acetic acid (Gd-DTPA) administration and the above-outlined evolution of the appearance of the adrenals confirm the diagnosis of adrenal hemorrhage and help to exclude the presence of tumor.
  • Ultrasonographic examination of the adrenals (including Doppler ultrasonography) is quite helpful in neonatal adrenal hemorrhage cases, and it may reveal the presence of adrenal hemorrhage in utero.
    • In older children or adults, ultrasonographic examination may be employed at the bedside, although it is operator dependent and may be limited by large body habitus.
    • Ultrasonographic imaging of adrenal hemorrhage reveals hyperechoic masses that contain a central echogenic area in the adrenal glands. Several weeks after the acute event, the central echogenicity associated with adrenal hemorrhage decreases as the hematomas become cystic.

Procedures

  • Percutaneous biopsy is helpful in establishing the presence of metastatic disease in cases of adrenal hemorrhage in which suggestive features appear on CT scans.

Histologic Findings

Examination of the adrenals in adrenal hemorrhage cases typically reveals extensive hemorrhagic necrosis involving all 3 adrenal cortical cell layers, in addition to adrenal medullary cell necrosis. The hemorrhage may extend into the perirenal fat and the perirenal space.

Other common findings include adrenal vein thrombosis and the retrograde migration of medullary cells into the zona fasciculata. In contrast, vasculitis rarely has been observed in cases of adrenal hemorrhage, suggesting that it has a limited role in the pathogenesis of adrenal hemorrhage.

At a more chronic stage, the hematoma becomes organized as a fibrous capsule that forms around the adrenal hemorrhagic area. Hemosiderin-laden macrophages are present in the capsule and digest cell debris. In the months following acute adrenal hemorrhage, fibrous tissue gradually replaces the hemorrhagic areas.

More on Adrenal Hemorrhage

Overview: Adrenal Hemorrhage
Differential Diagnoses & Workup: Adrenal Hemorrhage
Treatment & Medication: Adrenal Hemorrhage
Follow-up: Adrenal Hemorrhage
Multimedia: Adrenal Hemorrhage
References
Further Reading

References

  1. Rao RH. Bilateral massive adrenal hemorrhage. Med Clin North Am. 1995;79(1):107-29. [Medline].

  2. Vella A, Nippoldt TB, Morris JC 3rd. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc. Feb 2001;76(2):161-8. [Medline].

  3. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med. Sep 22 2005;353(12):1245-51. [Medline][Full Text].

  4. Pianta M, Varma DK. Bilateral spontaneous adrenal haemorrhage complicating acute pancreatitis. Australas Radiol. Apr 2007;51(2):172-4. [Medline].

  5. Gutenberg A, Lange B, Gunawan B, et al. Spontaneous adrenal hemorrhage: a little-known complication of intracranial tumor surgery. Case report. J Neurosurg. Jun 2007;106(6):1086-8. [Medline].

  6. Arnason JA, Graziano FM. Adrenal insufficiency in the antiphospholipid antibody syndrome. Semin Arthritis Rheum. Oct 1995;25(2):109-16. [Medline].

  7. Caron P, Chabannier MH, Cambus JP, et al. Definitive adrenal insufficiency due to bilateral adrenal hemorrhage and primary antiphospholipid syndrome. J Clin Endocrinol Metab. May 1998;83(5):1437-9. [Medline][Full Text].

  8. Vasinanukorn P, Rerknimitr R, Sriussadaporn S, et al. Adrenal hemorrhage as the first presentation of hepatocellular carcinoma. Intern Med. 2007;46(21):1779-82. [Medline][Full Text].

  9. Gavrilova-Jordan L, Edmister WB, Farrell MA, et al. Spontaneous adrenal hemorrhage during pregnancy: a review of the literature and a case report of successful conservative management. Obstet Gynecol Surv. Mar 2005;60(3):191-5. [Medline].

  10. Shah HR, Love L, Williamson MR, et al. Hemorrhagic adrenal metastases: CT findings. J Comput Assist Tomogr. Jan-Feb 1989;13(1):77-81. [Medline].

  11. Sinelnikov AO, Abujudeh HH, Chan D, et al. CT manifestations of adrenal trauma: experience with 73 cases. Emerg Radiol. Mar 2007;13(6):313-8. [Medline].

  12. Itoh K, Yamashita K, Satoh Y, et al. MR imaging of bilateral adrenal hemorrhage. J Comput Assist Tomogr. Nov-Dec 1988;12(6):1054-6. [Medline].

  13. Bhatia KS, Ismail MM, Sahdev A, et al. (123)I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol (Oxf). Apr 3 2008;[Medline].

  14. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. Sep 30 1999;341(14):1013-20. [Medline][Full Text].

  15. Jahangir-Hekmat M, Taylor HC, Levin H, et al. Adrenal insufficiency attributable to adrenal hemorrhage: long-term follow-up with reference to glucocorticoid and mineralocorticoid function and replacement. Endocr Pract. Jan-Feb 2004;10(1):55-61. [Medline].

  16. Dahlberg PJ, Goellner MH, Pehling GB. Adrenal insufficiency secondary to adrenal hemorrhage. Two case reports and a review of cases confirmed by computed tomography. Arch Intern Med. Apr 1990;150(4):905-9. [Medline].

  17. Duffy TP. Clinical problem-solving. The sooner the better [see comments]. N Engl J Med. Sep 2 1993;329(10):710-3. [Medline].

  18. Espinosa G, Santos E, Cervera R, et al. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore). Mar 2003;82(2):106-18. [Medline].

  19. Giraud T, Dhainaut JF, Schremmer B, et al. Adult overwhelming meningococcal purpura. A study of 35 cases, 1977-1989. Arch Intern Med. Feb 1991;151(2):310-6. [Medline].

  20. Hiroi N, Yanagisawa R, Yoshida-Hiroi M, et al. Retroperitoneal hemorrhage due to bilateral adrenal metastases from lung adenocarcinoma. J Endocrinol Invest. Jun 2006;29(6):551-4. [Medline].

  21. Korobkin M, Francis IR. Adrenal imaging. Semin Ultrasound CT MR. Aug 1995;16(4):317-30. [Medline].

  22. Kovacs KA, Lam YM, Pater JL. Bilateral massive adrenal hemorrhage. Assessment of putative risk factors by the case-control method. Medicine (Baltimore). Jan 2001;80(1):45-53. [Medline].

  23. Rao RH, Vagnucci AH, Amico JA. Bilateral massive adrenal hemorrhage: early recognition and treatment. Ann Intern Med. Feb 1 1989;110(3):227-35. [Medline].

  24. Schuchmann JA, Friedman PA. Bilateral adrenal hemorrhage: an unusual complication after bilateral total knee arthroplasty. Am J Phys Med Rehabil. Nov 2005;84(11):899-903. [Medline].

  25. Shifren JL. The role of androgens in female sexual dysfunction. Mayo Clin Proc. Apr 2004;79(4 Suppl):S19-24. [Medline].

  26. Siu SC, Kitzman DW, Sheedy PF 2nd, et al. Adrenal insufficiency from bilateral adrenal hemorrhage. Mayo Clin Proc. May 1990;65(5):664-70. [Medline].

  27. Takebayashi K, Aso Y, Tayama K, et al. Primary antiphospholipid syndrome associated with acute adrenal failure. Am J Med Sci. Jan 2003;325(1):41-4. [Medline].

  28. Varon J, Chen K, Sternbach GL. Rupert Waterhouse and Carl Friderichsen: adrenal apoplexy. J Emerg Med. Jul-Aug 1998;16(4):643-7. [Medline].

Keywords

AH, adrenal apoplexy, adrenal hemorrhagic necrosis, Waterhouse-Friderichsen syndrome, acute adrenal crisis, adrenocorticotropic hormone, ACTH, corticotropin, bilateral gland, necrosis, medullary adrenal cells, adrenal vein thrombosis

Contributor Information and Disclosures

Author

Nicholas A Tritos, MD, DSc, MMSc, FACE, FACP, Assistant Professor of Medicine, Tufts University School of Medicine; Senior Staff Physician, Department of Endocrinology, Lahey Clinic Medical Center
Nicholas A Tritos, MD, DSc, MMSc, FACE, FACP is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Physicians-American Society of Internal Medicine, American Medical Association, Endocrine Society, Massachusetts Medical Society, and Pituitary Society
Disclosure: Nothing to disclose.

Medical Editor

Dimitris A Papanicolaou, MD, Assistant Professor, Department of Medicine/Endocrinology, Emory University
Dimitris A Papanicolaou, MD is a member of the following medical societies: American College of Physicians, Endocrine Society, and Royal Society of Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS, Professor of Medicine (Endocrinology, Adj), Johns Hopkins School of Medicine; Affiliate Research Professor, Bioinformatics and Computational Biology Program, School of Computational Sciences, George Mason University; Principal, C/A Informatics, LLC
Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Endocrinology, American College of Nutrition, American College of Physician Executives, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Medical Informatics Association, American Society for Bone and Mineral Research, American Society of Law Medicine and Ethics, Endocrine Society, and International Society for Clinical Densitometry
Disclosure: Nothing to disclose.

CME Editor

Mark Cooper, MBBS, PhD, FRACP, Head, Diabetes & Metabolism Division, Baker Heart Research Institute, Professor of Medicine, Monash University
Disclosure: Nothing to disclose.

Chief Editor

George T Griffing, MD, Professor of Medicine, St Louis University School of Medicine
George T Griffing, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Medical Practice Executives, American College of Physician Executives, American College of Physicians, American Diabetes Association, American Federation for Medical Research, American Heart Association, Central Society for Clinical Research, Endocrine Society, International Society for Clinical Densitometry, and Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.